Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex in patients with liver dysfunction
NCT05028088Phase 4Unknown
- Start
- Jul 2021
- Primary completion
- Dec 2022
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB). Status: unknown.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT05028088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05028088.